This is a standard Form 3 filing for a new officer. No trading signal. Monitor for any future Form 4 filings by Bergwerk for open-market purchases or sales that could indicate insider conviction.
Price Chart
Executive Summary
Dov Bergwerk filed a Form 3 initial statement of beneficial ownership upon becoming Interim Chief Legal Officer of Teva Pharmaceutical Industries Ltd. The filing discloses 11,943 ordinary shares directly owned, along with stock options and restricted share units vesting through 2030. This is a routine insider initial ownership report with no trading activity or material financial implications.
Key Facts
- Dov Bergwerk appointed Interim Chief Legal Officer of Teva
- Direct ownership: 11,943 ordinary shares
- Stock options: 17,505 shares at $34.70 (exp. 2027-03-03) and 8,755 shares at $28.98 (exp. 2027-05-24)
- Restricted share units: 83,418 total across six grant tranches vesting through 2030
- Form 3 filed 2026-10-08, period of report 2026-09-29
Financial Impact
No financial impact, routine insider initial ownership filing
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-417902 |
| Document: 0001193125-26-417902-index.html | 0001193125-26-417902 |
| Document: 0001193125-26-417902.txt | 0001193125-26-417902 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 2d ago | Press Release | $40.39 | awaiting T+60 | awaiting T+60 | $40.91 (+1.29%) |
Oct 15, 2026 13d ago | Institutional Cluster | $41.11 | awaiting T+60 | awaiting T+60 | $40.91 (+0.49%) |
Oct 8, 2026 20d ago | 3 | $41.10 | awaiting T+60 | awaiting T+60 | $40.91 (−0.46%) |
Oct 2, 2026 27d ago | Press Release | $39.53 | awaiting T+60 | awaiting T+60 | $40.91 (+3.49%) |
Oct 2, 2026 27d ago | Press Release | $39.53 | awaiting T+60 | awaiting T+60 | $40.91 (+3.49%) |
Sep 30, 2026 28d ago | Press Release | $39.31 | awaiting T+60 | awaiting T+60 | $40.91 (+4.07%) |
Sep 28, 2026 4w ago | Press Release | $39.81 | awaiting T+60 | awaiting T+60 | $40.91 (+2.76%) |
Sep 23, 2026 5w ago | Press Release | $40.22 | awaiting T+60 | awaiting T+60 | $40.91 (+1.72%) |
Sep 23, 2026 5w ago | Press Release | $40.22 | awaiting T+60 | awaiting T+60 | $40.91 (+1.72%) |
Sep 22, 2026 5w ago | Insider Cluster | $39.01 | awaiting T+60 | awaiting T+60 | $40.91 (−4.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers